Current opinion in psychiatry An international review journal
Foncoo Company Participated in the Fifth Xiangya Psychiatric International Forum and Held Seminar
Review of “Red Lines for Enterprises”: Eight Disciplines Obeyed by Foncoo Pharmaceutical in Building “Incorruptible Culture”
Attending 15th Annual Meeting of Chinese Psychiatrist Association and Holding a Special Meeting
Annual Work Summary & Commendation Meeting of Foncoo Pharmaceutical Convened Smoothly
Olanzapine Tablets Passed Consistency Evaluation for Generic Drugs
Recently, Oranzi® olanzapine tablets (specification: 5mg*20 tablets, 10mg*20 tablets), which is distributed by Shenzhen Foncoo Pharmaceutical Co., Ltd., passed the national generic drugs quality and efficacy consistency evaluation.Oranzi is produced by Dr. Reddy’s Laboratories of India using US cGMP standards, but its price is similar to other olanzapine generics.In 2011, Oranzi was approved by the US FDA and was the first olanzapine generic drug in the United States. In that year, its market share exceeded that of the olanzapine original drug; in Europe, one in every two patients taking olanzapine takes Oranzi.Oranzi submitted generic drug consistency evaluation data in China in October 2018 and passed the review in early September 2019.So far, in addition to the Olanzapine original drug in the domestic market, Oranzi is the only olanzapine tablet certified by the US FDA, the European Union EMEA, and China Consistency Evaluation.
- Shenzhen Foncoo Pharmaceutical Co., Ltd.
- Add：Unit 701,Block A,Guoren Building,Keji Middle 3rd Road,Hi-Tech Park,Nanshan District,Shenzhen,China.